SCHEMBL4780181

SCHEMBL4780181

FC(F)(F)N1C[CH]CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2100535 0.75 CYP2B6 (0.30)
SCHEMBL7048888 0.68
SCHEMBL518019 0.68
SCHEMBL8987275 0.67
SCHEMBL1044754 0.66
Hydrochloric Acid SCHEMBL16238627 0.66
SCHEMBL10006193 0.66
SCHEMBL1043045 0.66
SCHEMBL4182918 0.65
SCHEMBL1515298 0.64 PAX8 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008038011-A1 PYRIMIDINE DERIVATIVES AS AURORA A AND AURORA B INHIBITORS VERNALIS (R & D) LIMITED (GB) 2008-04-03 WO claimed
WO-2008038010-A1 PYRAZINE DERIVATIVES AND THEIR USE IN THERAPY VERNALIS (R & D) LIMITED (GB) 2008-04-03 WO claimed
WO-2008038010-A1 PYRAZINE DERIVATIVES AND THEIR USE IN THERAPY VERNALIS (R & D) LIMITED (GB) 2008-04-03 WO disclosed
WO-2008038011-A1 PYRIMIDINE DERIVATIVES AS AURORA A AND AURORA B INHIBITORS VERNALIS (R & D) LIMITED (GB) 2008-04-03 WO disclosed